Concord Wealth Partners
BIIB icon

Concord Wealth Partners’s Biogen BIIB Stock Holding History

Concord Wealth Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$25.8K Hold
114
– – ﹤0.01% 435
2026
Q2 		$24.6K Buy
+114
New +$21.8K ﹤0.01% 453
2026
Q1 		– Sell
-114
Closed -$20.1K – 259
2025
Q4 		$20.1K Hold
114
– – ﹤0.01% 442
2025
Q3 		$16K Sell
114
-114
-50% -$15.4K ﹤0.01% 480
2025
Q2 		$28.6K Buy
228
+114
+100% +$14.2K ﹤0.01% 415
2025
Q1 		$15.6K Hold
114
– – ﹤0.01% 459
2024
Q4 		$17.4K Buy
114
+78
+217% +$13.2K ﹤0.01% 477
2024
Q3 		$6.98K Sell
36
-88
-71% -$18.4K ﹤0.01% 593
2024
Q2 		$28.7K Sell
124
-100
-45% -$21.7K 0.01% 376
2024
Q1 		$48.3K Sell
224
-533
-70% -$125K 0.01% 355
2023
Q4 		$196K Buy
757
+86
+13% +$21.1K 0.04% 198
2023
Q3 		$172K Buy
671
+557
+489% +$149K 0.04% 210
2023
Q2 		$32.5K Hold
114
– – 0.01% 421
2023
Q1 		$31.7K Sell
114
-3
-3% -$830 0.01% 415
2022
Q4 		$32.4K Buy
+117
New +$33K 0.01% 458
2022
Q3 		– Sell
-120
Closed -$24K – 259
2022
Q2 		$24K Sell
120
-120
-50% -$24.5K 0.01% 503
2022
Q1 		$51K Sell
240
-25
-9% -$5.44K 0.01% 433
2021
Q4 		$64K Buy
265
+241
+1,004% +$62K 0.02% 407
2021
Q3 		$7K Sell
24
-105
-81% -$34.4K ﹤0.01% 524
2021
Q2 		$45K Buy
129
+10
+8% +$3.03K 0.01% 369
2021
Q1 		$33K Sell
119
-225
-65% -$60.7K 0.01% 399
2020
Q4 		$84K Buy
+344
New +$88.7K 0.06% 147

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Concord Wealth Partners's BIIB Position: Q3 2026 in Review

Concord Wealth Partners held its Biogen (BIIB) position steady in Q3 2026 at 114 shares worth $25.8K. The position accounts for ﹤0.01% of the portfolio, ranked #435.

Concord Wealth Partners first reported a position in BIIB in Q4 2020 and has held it in 22 quarters since. The position peaked at $196K in Q4 2023. 643 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Concord Wealth Partners held 114 shares of Biogen worth $25.8K as of Q3 2026.
  • Concord Wealth Partners left its Biogen share count unchanged in Q3 2026.
  • Biogen made up ﹤0.01% of Concord Wealth Partners's portfolio in Q3 2026, its #435 holding.
  • Concord Wealth Partners first reported a position in Biogen in Q4 2020 and has held it in 22 quarters since.
  • Concord Wealth Partners's Biogen position peaked at $196K in Q4 2023.
  • 643 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Concord Wealth Partners's 13F filing for Q3 2026, filed 2 Nov 2026.